Home » Topics » BioWorld Science

BioWorld Science
RSS

Bayer and collaborators patent CSNK1 inhibitors

Feb. 25, 2022

Evaluating effect of LyeTxI-b on colorectal cancer using chicken chorioallantoic membrane model

Feb. 25, 2022

Redox-tuned [18F]4FN radiopharmaceutical is useful for imaging innate immunity activation

Feb. 25, 2022

Risk SNP for COVID-19 signals protection against HIV

Feb. 24, 2022

GliaPharm and Wyss Center collaborate on new treatments for Alzheimer's disease

Feb. 24, 2022

IL-9/ARG1/macrophage axis targeting for the treatment of allergic airway inflammation

Feb. 24, 2022

Identification of novel antifungal and antibacterial compounds

Feb. 24, 2022

ConserV receives funding to advance pan-coronavirus vaccine candidate UNICOR-v

Feb. 24, 2022

Jnana selects JNT-517 as development candidate for phenylketonuria

Feb. 24, 2022

Financing at Plexium supports progression of pipeline of targeted protein degradation therapies

Feb. 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...